In addition, we did not find any differences in the genotype distribution among patients with different severities of COPD (GOLD stages), suggesting the role of factors varying from the deletion polymorphisms of GSTM1 and GSTT1 in the progression of this disease. This evidence concerns the gene GSTM1 and chronic obstructive pulmonary disease.